Literature DB >> 2495881

An in-vitro assessment of the functional activity of monoclonal anti-D.

A G Hadley1, B M Kumpel, K Leader, A H Merry, E Brojer, B Zupanska.   

Abstract

The response of human monocytes to red cells sensitized with known levels of monoclonal antibody to the Rh antigen D (anti-D) was compared with that of polyclonal anti-D. Monocyte response was determined by measuring red cell adherence, erythrophagocytosis, monocyte-mediated red cell lysis and luminol-dependent chemiluminescence. By all criteria, monoclonal and polyclonal antibodies showed comparable activity, with IgG3 antibodies promoting a greater monocyte-red cell interaction than IgG1 antibodies. It is suggested that monoclonal anti-D may be effective in the prophylaxis of haemolytic disease of the newborn, providing such material is clinically acceptable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495881     DOI: 10.1111/j.1365-2257.1989.tb00173.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  3 in total

1.  Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.

Authors:  A G Hadley; B M Kumpel
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

2.  Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers.

Authors:  J Goodrick; B Kumpel; D Pamphilon; I Fraser; G Chapman; B Dawes; D Anstee
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

3.  Glycosylation and functional activity of anti-D secreted by two human lymphoblastoid cell lines.

Authors:  D Cant; J Barford; C Harbour; A Fletcher; N Packer; A Gooley
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.